| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-08 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.21 |
1e-05 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.0001 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |